Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Non-Current Liabilities (2021 - 2025)

Korro Bio (KRRO) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities rose 113.67% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, up 113.67%, and an annual FY2024 reading of $1.5 million, up 39.79% over the prior year.
  • Other Non-Current Liabilities was $1.5 million for Q3 2025 at Korro Bio, up from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.5 million in Q3 2025 and bottomed at $57000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $763642.9, with a median of $805000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities plummeted 82.56% in 2022, then skyrocketed 113.67% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $87000.0 in 2021, then dropped by 9.2% to $79000.0 in 2022, then skyrocketed by 1232.91% to $1.1 million in 2023, then skyrocketed by 39.79% to $1.5 million in 2024, then increased by 4.08% to $1.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for KRRO at $1.5 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.